IE
Insider Edges

DEEP TRACK CAPITAL, LP 13F portfolio summary

DEEP TRACK CAPITAL, LP of DEEP TRACK CAPITAL, LP has 67 current stock holdings with a reported portfolio value of $6.87B. The portfolio 1 year return is +107.36%. Top holdings include GH (7.41%), IMVT (5.24%), PCVX (3.64%), ALNY (3.61%), MANE (3.58%).

Back to investors

DEEP TRACK CAPITAL, LP

DEEP TRACK CAPITAL, LP
Latest filing: 2026-06-30

DEEP TRACK CAPITAL, LP runs DEEP TRACK CAPITAL, LP and currently holds 67 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $6.87B. Their top holdings are GH, IMVT, PCVX, ALNY, MANE. The top five represent 23.5% of reported portfolio weight. DEEP TRACK CAPITAL, LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, DEEP TRACK CAPITAL, LP initiated 13 new positions. They added to 19 existing positions. They trimmed 11 positions. Their current best-performing preview position is CMPS with returns of +155.88%.

Sign in to enable email alerts for this investor.
Top 5 Holdings
GH7.4%
IMVT5.2%
PCVX3.6%
ALNY3.6%
MANE3.6%
Top 5: 23.5%
Portfolio Returns
1 Year
+107.36%
#0/1000
3 Year
+113.32%
#0/1000
5 Year
+98.70%
#0/1000

Portfolio Value

$6.87B

Alpha Score

97.1

#0 of 1000

Holdings

67

Showper page

67 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change
GH
GUARDANT HEALTH INC
7.41%$40.05$170.69+326.19%
Added
+1.65%
IMVT
IMMUNOVANT INC
5.24%$22.63$44.37+96.07%
Trimmed
-18.96%
PCVX
VAXCYTE INC
3.64%$39.08$62.62+60.24%
Held
ALNY
ALNYLAM PHARMACEUTICALS INC
3.61%$301.03$236.22-21.53%
New Buy
MANE
VERADERMICS INC
3.58%$107.99$102.97-4.65%
Added
+300.00%
TARS
TARSUS PHARMACEUTICALS INC
3.36%$56.63$72.70+28.38%
Added
+1.85%
NUVL
NUVALENT INC
3.21%$107.25$123.96+15.58%
Added
+29.57%
ALKS
ALKERMES PLC
3.05%$33.42$48.33+44.61%
Added
+11.41%
OCUL
OCULAR THERAPEUTIX INC
2.81%$7.38$11.08+50.14%
Held
BMRN
BIOMARIN PHARMACEUTICAL INC
2.75%$57.97$66.70+15.06%
Added
+187.61%

Showing 1-10 of 67